高级检索+

基于网络药理学和分子对接探究药膳“枸杞-桑椹-覆盆子汤”治疗糖尿病肾病的分子机制

Molecular Mechanism of Medicated Diet ’Chinese Wolfberry-Mulberry-Raspberry Decoction’ in the Treatment of Diabetic Kidney Disease Based on Network Pharmacology and Molecular Docking

  • 摘要: 传统食物与中药结合而成的特殊膳饮“枸杞-桑椹-覆盆子汤”是中华民族食疗养生文化瑰宝,其成分桑椹、枸杞和覆盆子具有降血脂、降血糖和治疗肾病等多种生理活性功能,对糖尿病肾病具有潜在的防治作用。采用网络药理学、分子对接和抗氧化测试等技术对其治疗糖尿病肾病的分子机制进行研究。运用TCMSP数据库进行“枸杞-桑椹-覆盆子汤”的活性成分及作用靶点收集,在GeneCards、OMIM、TTD和DisGeNET数据库获取糖尿病肾病相关靶点。取活性成分和疾病交集靶点,运用STRING数据库和Cytoscape 3.8.0构建“活性成分-疾病靶点”相互作用网络。基于相互作用网络,利用DAVID数据库对交集靶点进行基因本体(GO)和京都基因与基因组百科全书(KEGG)通路富集分析,并借助Cytoscape 3.8.0中的MCODE和CytoHubba进行关键靶点筛选。利用AutoDock Vina对关键靶点与活性成分进行分子对接,评估关键靶点与活性成分之间的结合能力与作用模式。基于糖尿病肾病-“枸杞-桑椹-覆盆子汤”共同作用靶点与核心团簇分析,筛选出β-谷甾醇、大豆黄素、桑色素、槲皮素、β-胡萝卜素和鞣花酸为活性作用成分,IL6、IL1B、PPARG、MMP9和VEGFA为核心作用靶点,分子对接结果显示,主要活性成分与靶点均具有较高结合能。通过“枸杞-桑椹-覆盆子汤”提取物对1,1-二苯基-2-三硝基苯肼(DPPH)自由基、羟基自由基和2,2-联氮-双-3-乙基苯并噻唑啉-6-磺酸(ABTS)阳离子自由基清除能力测试试验发现“,枸杞-桑椹-覆盆子汤”具有较高的抗氧化能力,对糖尿病肾病可起到保护作用。该研究初步揭示了“枸杞-桑椹-覆盆子汤”以“多成分-多靶点-多通路”模式协同治疗糖尿病肾病的作用机制与抗氧化机制,为传统药膳“枸杞-桑椹-覆盆子汤”的产业化应用提供了理论依据。

     

    Abstract: The special diet and drink ’Chinese wolfberry-mulberry-raspberry decoction’, which is a combination of traditional food and Chinese medicine, is a treasure of Chinese dietotherapy and health preservation culture. Its ingredients, mulberry, wolfberry and raspberry, have a variety of physiological activities, such as lowering blood fat, blood sugar and curing kidney disease, and have potential preventive and therapeutic effects on diabetes and kidney disease. In this study, network pharmacology, molecular docking and antioxidant test were used to study the molecular mechanism of medicated diet ’Chinese wolfberry-mulberry-raspberry decoction’ in the treatment of diabetes nephropathy. TCMSP database was used to collect the active ingredients and action targets of ’Chinese wolfberry-mulberry-raspberry decoction’, and the targets related to diabetes nephropathy were obtained from GeneCards, OMIM, TTD and DisGeNET databases. Taking the intersection targets of active ingredient in ’Chinese wolfberry-mulberry-raspberry decoction’and the disease, the interaction network of ’Chinese wolfberry-mulberry-raspberry decoction active ingredient-disease target’was constructed by using STRING database and Cytoscape 3.8.0. Based on the interaction network, the gene ontology(GO) and Kyoto Encyclopedia of Genes(KEGG) pathways enrichment analysis of the intersection targets were performed using the DAVID database, and the MCODE and CytoHubba in Cytoscape 3.8.0 were used to screen key targets. Molecular docking were performed using AutoDock Vina program to evaluate the binding ability and action mode between key targets and active ingredients. Based on the analysis of co-targets and core clusters of diabetes nephropathy and ’Chinese wolfberry-mulberry-raspberry decoction’, β-sitosterol, daidzein, morin, quercetin β-carotene and ellagic acid were screened as the active components, and IL6, IL1B, PPARG, MMP9 and VEGFA as the core action targets. Molecular docking results showed that both the main active components and the targets had high binding energy The results of the eliminate ability tests of ’Chinese wolfberry-mulberry-raspberry decoction’extract to 1,1-diphenyl-2-picrylhydrazyl(DPPH) radical, hydroxyl radical and 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)(ABTS) radical cation showed that ’Chinese wolfberry-mulberry-raspberry decoction’had high antioxidant capacity and could play a protective role in nephrotic diabetes. This study preliminarily revealed the mechanism of action and antioxidant mechanism of ’Chinese wolfberry-mulberry-raspberry decoction’in the collaborative treatment of diabetes nephropathy in the mode of ’multi-component multi target multi pathway’, which provides a theoretical basis for the industrial application of traditional medicinal diet ’Chinese wolfberry-mulberry-raspberry decoction’.

     

/

返回文章
返回